Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil

被引:15
|
作者
Le Marchand, Chloe [1 ]
Bahia, Fabianna [2 ]
Page, Kimberly [3 ]
Brites, Carlos [2 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Fed Bahia UFBA, Dept Infect Dis, BR-40110160 Salvador, BA, Brazil
[3] Univ New Mexico, Div Epidemiol Biostat & Prevent Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
关键词
HTLV-1; HIV; Hepatitis C; Brazil; Spontaneous HCV clearance; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; VIRAL CLEARANCE; GENERAL-POPULATION; HCV INFECTION; COINFECTION; EPIDEMIOLOGY; REINFECTION; IMMUNITY; DISEASE;
D O I
10.1016/j.bjid.2015.06.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: While 20-40% of patients with hepatitis C virus (HCV) monoinfection will spontaneously clear the virus, less is known regarding clearance with coinfections. HCV, human immunodeficiency virus (HIV), and human T-cell lymphotrophic virus 1 and 2 (HTLV-1/2) coinfection occurs due to shared routes of transmission and is prevalent in Brazil. Objectives: To compare the proportion of patients who have spontaneously cleared HCV in patients with HCV monoinfection to patients coinfected by HCV/HIV, or HCV/HIV/HTLV-1. Methods: Using medical records from two clinics in Salvador, Brazil, including demographic data and serological markers of HCV, HIV and HTLV-I/II, cross-sectional data was obtained from 197 patients. Patients who were anti-HCV positive and HCV RNA negative, and who did not receive HCV treatment were defined as having cleared infection. Results: Nineteen patients (9.5%) showed evidence of spontaneous HCV clearance; with clearance in 9 of 108 (8.3%) patients in the HCV monoinfected group, 5 of 68 (7.4%) patients with HCV/HIV, and 5 of 21 (23.8%) patients with HCV/HIV/HTLV. Demographic data were not associated with HCV clearance status. Patients coinfected with both HIV and HTLV-1 had increased odds (5.50; 95% CI 1.00, 30.17) of spontaneous clearance of HCV compared with patients who were HIV negative or of unknown HIV status. Conclusion: Our study found that patients coinfected with HIV and HTLV-1 were more likely to spontaneously clear hepatitis C virus than patients with HIV/HCV or HCV alone. The effects of HTLV coinfection on the immune response of such patients may be associated with these findings. (C) 2015 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 50 条
  • [41] Impact of HIV co-infection on immunological biomarker profile of HTLV-1 infected patients
    Borges Starling, Ana Lucia
    Souza Pereira, Silvio Roberto
    Peruhype-Magalhaes, Vanessa
    Alves Coelho-dos-Reis, Jordana Grazziela
    Bicalho, Kelly Alves
    de Paiva, Luciene Pimenta
    Martins, Julia Pereira
    Trindade, Bruno Caetano
    Labanca, Ludimila
    Faccioli, Lucia Helena
    Lambertucci, Jose Roberto
    dos Santos Silva, Luciana Cristina
    de Figueiredo Antunes, Carlos Mauricio
    Teixeira-Carvalho, Andrea
    de Freitas Carneiro-Proietti, Anna Barbara
    Goncalves, Denise Ustch
    Martins-Filho, Olindo Assis
    IMMUNOLOGY LETTERS, 2021, 236 : 68 - 77
  • [42] Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France
    Cacoub, Patrice
    Dabis, Francois
    Costagliola, Dominique
    Almeida, Kayigan
    Lert, France
    Piroth, Lionel
    Semaille, Caroline
    LIVER INTERNATIONAL, 2015, 35 (01) : 65 - 70
  • [43] Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals
    Ferns, R. Bridget
    Tarr, Alexander W.
    Hue, Stephane
    Urbanowicz, Richard A.
    McClure, C. Patrick
    Gilson, Richard
    Ball, Jonathan K.
    Nastouli, Eleni
    Garson, Jeremy A.
    Pillay, Deenan
    VIROLOGY, 2016, 492 : 213 - 224
  • [44] Factors Associated with Spontaneous Clearance of Recently Acquired Hepatitis C Virus among HIV-Positive Men in Brazil
    Ferrufino, Rosario Quiroga
    Rodrigues, Camila
    Figueiredo, Gerusa Maria
    Gleison, Daniel
    Yapura, Silvia
    de Matos, Maria Laura Mariano
    Witkin, Steven S. S.
    Mendes-Correa, Maria Cassia
    VIRUSES-BASEL, 2023, 15 (02):
  • [45] Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus
    Dimitroulis, Dimitrios
    Valsami, Serena
    Spartalis, Eleftherios
    Pikoulis, Emmanuel
    Kouraklis, Gregory
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (06) : 323 - 327
  • [46] Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis
    Manfredi, R.
    Dentale, N.
    Calza, L.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (03) : E48 - E50
  • [47] Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft
    Antonini, Teresa M.
    Furlan, Valerie
    Teicher, Elina
    Haim-Boukobza, Stephanie
    Sebagh, Mylene
    Coilly, Audrey
    Bonhomme-Faivre, Laurence
    Peytavin, Gilles
    Roque-Afonso, Anne-Marie
    Vittecoq, Daniel
    Samuel, Didier
    Taburet, Anne-Marie
    Duclos-Vallee, Jean-Charles
    AIDS, 2013, 27 (16) : 2655 - 2657
  • [48] Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV
    Lorna Laufer, Natalia
    Rockstroh, Juergen Kurt
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (02) : 157 - 164
  • [49] Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus
    Dimitrios Dimitroulis
    Serena Valsami
    Eleftherios Spartalis
    Emmanuel Pikoulis
    Gregory Kouraklis
    World Journal of Hepatology, 2013, (06) : 323 - 327
  • [50] Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a “special population”?
    Drosos E Karageorgopoulos
    Joanna Allen
    Sanjay Bhagani
    World Journal of Hepatology, 2015, (15) : 1936 - 1952